Erythromycin
NDC 73082-020, Erythromycin, tablet, film coated, from Orange Pharmaceuticals USA LLC.
- Product NDC
- 73082-020
- Status
- Listed
- Labeler
- Orange Pharmaceuticals USA LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213628
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73082-020 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ERYTHROMYCIN500 mg/1
Pharmacologic classes
Decreased Sebaceous Gland Activity [PE]; Macrolide Antimicrobial [EPC]; Macrolide [EPC]; Macrolides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73082-020-01 | 73082002001 | 100 TABLET, FILM COATED in 1 BOTTLE (73082-020-01) |
| 73082-020-30 | 73082002030 | 30 TABLET, FILM COATED in 1 BOTTLE (73082-020-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/379ed8f7-b54f-495f-932e-cd0e4c691134
Use it
Look up 73082-020 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73082-020 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73082-020. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.